跳至主要内容
临床试验/CTRI/2023/10/058283
CTRI/2023/10/058283已完成Unknown

The efficacy of administration of a single dose tranexamic acid intravenously in the reduction of blood loss following a unilateral primary total knee replacement surgery - N/A

Sriman Narayan M0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients undergoing Unilateral Total Knee Replacement.
  • 2. Both sexes.
  • 3. Patients with Hemoglobin levels equal to more than 11g/dL.
  • 4. Coagulation profile within normal limits.

排除标准

  • 1. Patients undergoing simultaneous bilateral Total Knee Replacement Surgery.
  • 2. Patient undergoing revision Knee Replacement surgeries.
  • 3. Known patients of bleeding disorders.
  • 4. Patients with known cases of Deep Vein Thrombosis, Pulmonary Embolism, and other vessel wall disorders.
  • 5. Known cases of hematological disorders.
  • 6. Known cases of renal insufficiency.
  • 7. Patients with a Wells Score 2 or more.
  • 8. Patients with a previous history of Cerebrovascular accidents, Transient Ischemic Attack, or Myocardial infarction.
  • 9. Patient with a known history of seizure disorder.
  • 10.Patients with known or suspected allergy to medication

研究者

发起方
Sriman Narayan M

相似试验